ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

WPCT Woodford Patient Capital Trust Plc

33.60
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Woodford Patient Capital Trust Plc LSE:WPCT London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 33.60 33.55 33.90 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Schroder UK Public Private Tst plc Net Asset Value(s) (8703N)

06/06/2022 2:17pm

UK Regulatory


Woodford Patient Capital (LSE:WPCT)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Woodford Patient Capital Charts.

TIDMSUPP

RNS Number : 8703N

Schroder UK Public Private Tst plc

06 June 2022

Schroder UK Public Private Trust plc

Net Asset Value ("NAV")

The Board of Schroder UK Public Private Trust plc (the "Company") announces the indicative unaudited NAV per share of the Company as follows:

 
  Date           NAV- pence per 
                  share 
 01 June 2022    37.70p 
                --------------- 
 

The above unaudited NAV reflects a revaluation of the quoted holdings at the market close price on the NAV reporting date. The unquoted holdings are now valued at 31 December 2021 and are revalued each quarter, however, daily foreign exchange movements on unquoted holdings have been reflected in the daily NAV.

The Company's holding in Rutherford Health plc ("RUTH") has historically been revalued quarterly in line with our valuation methodology for unquoted holdings. The Company continues to value RUTH on this basis following the withdrawal of its shares from trading on the AQSE Growth Market on 24 January 2022.

Quarterly valuations are released within four months of the Company's 31 December year end, within three months of the half-year period end, and within two months of the other quarterly valuation points. The last valuation date for private assets was 31 December 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVUPUQGQUPPGWQ

(END) Dow Jones Newswires

June 06, 2022 09:17 ET (13:17 GMT)

1 Year Woodford Patient Capital Chart

1 Year Woodford Patient Capital Chart

1 Month Woodford Patient Capital Chart

1 Month Woodford Patient Capital Chart

Your Recent History

Delayed Upgrade Clock